Increased oxidative stress in obesity and its impact on metabolic syndrome.
暂无分享,去创建一个
Morihiro Matsuda | Makoto Makishima | Masanori Iwaki | Osamu Nakayama | M. Matsuda | M. Makishima | I. Shimomura | T. Fujita | O. Nakayama | M. Shimabukuro | Iichiro Shimomura | M. Iwaki | Michio Shimabukuro | Takuya Fujita | Shigetada Furukawa | Yukio Yamada | Yoshimitsu Nakajima | S. Furukawa | Yukio Yamada | Y. Nakajima
[1] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[2] S. O’Rahilly,et al. Metabolism: Partial leptin deficiency and human adiposity , 2001, Nature.
[3] M. Matsuda,et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.
[4] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[5] R. Hammer,et al. Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. , 1990, Science.
[6] E. Benjamin,et al. Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[7] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.
[8] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[9] J. Lawrence,et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. , 2001, Diabetes.
[10] John Beilby,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004 .
[11] J. Sasaki,et al. Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[13] D. Harrison,et al. Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.
[14] A. Greenberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .
[15] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[16] P. Froguel,et al. Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.
[17] T. Mayumi,et al. Nitration of PPARγ inhibits ligand‐dependent translocation into the nucleus in a macrophage‐like cell line, RAW 264 , 2002, FEBS letters.
[18] S. Kihara,et al. Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.
[19] S. Jacob,et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. , 1999, Free radical biology & medicine.
[20] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Lazar,et al. Regulation of Fasted Blood Glucose by Resistin , 2004, Science.
[22] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[23] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[24] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[25] T. Funahashi,et al. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive Substances , 1999, Annals of the New York Academy of Sciences.
[26] R. Curi,et al. Pancreatic β-Cells Express Phagocyte-Like NAD(P)H Oxidase , 2003 .
[27] B. '. ’t Hart,et al. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. , 1990, Free radical biology & medicine.
[28] A. Rudich,et al. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. , 1998, Diabetes.
[29] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[30] Yizhong Zhang,et al. Expression of Nox4 in osteoclasts , 2004, Journal of cellular biochemistry.
[31] H. Motoshima,et al. The NAD(P)H Oxidase Homolog Nox4 Modulates Insulin-Stimulated Generation of H2O2 and Plays an Integral Role in Insulin Signal Transduction , 2004, Molecular and Cellular Biology.
[32] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[33] H. Utsumi,et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.
[34] A. Dorrance,et al. NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat , 2001, Hypertension.
[35] P. Scherer,et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.
[36] C. Kahn,et al. Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.
[37] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[38] H. Kaneto,et al. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. , 1997, The Journal of clinical investigation.
[39] T. Roskams,et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. , 2003, The American journal of pathology.
[40] P. Scherer,et al. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.
[41] P. Ferré,et al. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. , 2002, American journal of physiology. Endocrinology and metabolism.
[42] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[43] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[44] J. Halaas,et al. Leptin and the regulation of body weight in mammals , 1998, Nature.
[45] M. Cotter,et al. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. , 2003, Life sciences.
[46] M. Hattori,et al. A Novel Superoxide-producing NAD(P)H Oxidase in Kidney* , 2001, The Journal of Biological Chemistry.
[47] H. Krieger-Brauer,et al. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. , 1992, The Journal of clinical investigation.
[48] S. O’Rahilly,et al. The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.
[49] M. Matsuda,et al. Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.
[50] R. Unger. The physiology of cellular liporegulation. , 2003, Annual review of physiology.
[51] H. Lodish,et al. ACRP30, a new hormone controlling fat and glucose metabolism. , 2002, European journal of pharmacology.
[52] H. Krieger-Brauer,et al. Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells. , 1995, The Biochemical journal.
[53] A. J. Valente,et al. PU.1 Is Essential for p47 phox Promoter Activity in Myeloid Cells* , 1997, The Journal of Biological Chemistry.
[54] Bruce M. Spiegelman,et al. Obesity and the Regulation of Energy Balance , 2001, Cell.
[55] D. Loskutoff,et al. Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Chang,et al. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells :a potential atherogenic source of reactive oxygen species. , 1999, Endothelium : journal of endothelial cell research.
[57] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[58] S. Kihara,et al. Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[59] Joseph L Evans,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.
[60] A. Rudich,et al. Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.
[61] Y. Suh,et al. Cell transformation by the superoxide-generating oxidase Mox1 , 1999, Nature.
[62] J. Friedman,et al. Obesity in the new millennium , 2000, Nature.
[63] D. Sorescu,et al. NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.
[64] W. R. Taylor,et al. Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.
[65] G. Cecchini,et al. Possible role of aldehydic lipid peroxidation products as chemoattractants. , 1987, International journal of tissue reactions.
[66] S. Olusi. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans , 2002, International Journal of Obesity.